A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES Trial-Reference-Cited by-同舟云学术

A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES Trial

Published:2022-01-21 Issue:1 Volume:12 Page:473-473
ISSN:1877-7171
Container-title:Journal of Parkinson's Disease
language:
Short-container-title:JPD

Author:

Abbruzzese Giovanni¹,Kulisevsky Jaime²,Bergmans Bruno³,Gomez-Esteban Juan C.⁴,Kägi Georg⁵,Raw Jason⁶,Stefani Alessandro⁷,Warnecke Tobias⁸,Jost Wolfgang H.⁹,

Affiliation:

1. DINOGMI, University of Genoa, Genova, Italy

2. Sant Pau Hospital, Universitat Aut‘onoma de Barcelona, CIBERNED, Barcelona, Spain

3. Department of Neurology, AZ St-Jan Brugge-Oostende AV, Campus Brugge, Brugge & Ghent University Hospital, Ghent, Belgium

4. Biocruces Research Institute, Barakaldo, Spain

5. Department of Neurology, Cantonal Hospital St.Gallen, Switzerland

6. Fairfield General Hospital, Bury, Greater Manchester, UK

7. Parkinson Center, University Policlinico Tor Vergata, Roma, Italy

8. Department of Neurology, University of Muenster, Muenster, Germany

9. Parkinson-Klinik Ortenau, University of Freiburg, Wolfach, Germany

Publisher

IOS Press

Subject

Cellular and Molecular Neuroscience,Neurology (clinical)

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safinamide, an inhibitor of monoamine oxidase, modulates the magnitude, gating, and hysteresis of sodium ion current;BMC Pharmacology and Toxicology;2024-02-08

2. Effectiveness and safety of safinamide in routine clinical practice in a Belgian Parkinson’s disease population: an open-label, levodopa add-on study;Acta Neurologica Belgica;2022-10-06

3. A critical appraisal of MAO-B inhibitors in the treatment of Parkinson’s disease;Journal of Neural Transmission;2022-02-02